Axsome Therapeutics, Inc.
DE ˙ DB ˙ US05464T1043
199,30 € ↑9,50 (5,01%)
2026-06-04
AKTIENPREIS
SecurityDE:19X / Axsome Therapeutics, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership401,459 shares
Latest Disclosed Value $ 67,854,600
Northern Trust Corp reports 2.82% increase in ownership of 19X / Axsome Therapeutics, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 401,459 shares of Axsome Therapeutics, Inc. (DE:19X) valued at $56,324,698 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 390,431 shares of Axsome Therapeutics, Inc.. This represents a change in shares of 2.82% during the quarter. The current value of the position is $80,010,779 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AXSOME THERAPEUTICS COM 05464T104 401,459 11,028 2.82 67,855 -4.84 0.0090
2026-02-17 2025-12-31 13F AXSOME THERAPEUTICS COM 05464T104 390,431 -19,104 -4.66 71,308 43.37 0.0091
2025-11-14 2025-09-30 13F AXSOME THERAPEUTICS COM 05464T104 409,535 141 0.03 49,738 16.38 0.0064
2025-08-13 2025-06-30 13F AXSOME THERAPEUTICS COM 05464T104 409,394 -1,575 -0.38 42,737 -10.84 0.0059
2025-05-13 2025-03-31 13F AXSOME THERAPEUTICS COM 05464T104 410,969 8,469 2.10 47,931 40.75 0.0071
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS COM 05464T104 402,500 69,918 21.02 34,056 13.94 0.0048
2024-11-13 2024-09-30 13F AXSOME THERAPEUTICS COM 05464T104 332,582 8,089 2.49 29,889 14.43 0.0049
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS COM 05464T104 324,493 -11,592 -3.45 26,122 -2.60 0.0044
2024-05-14 2024-03-31 13F AXSOME THERAPEUTICS COM 05464T104 336,085 -7,223 -2.10 26,820 -1.84 0.0046
2024-02-13 2023-12-31 13F AXSOME THERAPEUTICS COM 05464T104 343,308 -5,749 -1.65 27,324 12.00 0.0049
2023-11-13 2023-09-30 13F AXSOME THERAPEUTICS COM 05464T104 349,057 22,916 7.03 24,396 4.09 0.0047
2023-08-11 2023-06-30 13F AXSOME THERAPEUTICS COM 05464T104 326,141 8,089 2.54 23,436 19.47 0.0045
2023-05-15 2023-03-31 13F AXSOME THERAPEUTICS COM 05464T104 318,052 6,107 1.96 19,617 -18.47 0.0039
2023-02-13 2022-12-31 13F AXSOME THERAPEUTICS COM 05464T104 311,945 23,993 8.33 24,060 87.27 0.0050
2022-11-14 2022-09-30 13F AXSOME THERAPEUTICS COM 05464T104 287,952 7,701 2.75 12,848 19.71 0.0029
2022-08-12 2022-06-30 13F AXSOME THERAPEUTICS COM 05464T104 280,251 -458 -0.16 10,733 -7.62 0.0023
2022-05-13 2022-03-31 13F AXSOME THERAPEUTICS COM 05464T104 280,709 -10,590 -3.64 11,618 5.57 0.0020
2022-02-08 2021-12-31 13F AXSOME THERAPEUTICS COM 05464T104 291,299 14,049 5.07 11,005 20.42 0.0018
2021-11-15 2021-09-30 13F AXSOME THERAPEUTICS COM 05464T104 277,250 -12,880 -4.44 9,139 -53.30 0.0016
2021-08-13 2021-06-30 13F AXSOME THERAPEUTICS COM 05464T104 290,130 -14,292 -4.69 19,571 13.54 0.0034
2021-05-12 2021-03-31 13F AXSOME THERAPEUTICS COM 05464T104 304,422 -13,608 -4.28 17,237 -33.47 0.0032
2021-02-11 2020-12-31 13F AXSOME THERAPEUTICS COM 05464T104 318,030 -34,703 -9.84 25,910 3.10 0.0050
2020-11-16 2020-09-30 13F AXSOME THERAPEUTICS COM 05464T104 352,733 -22,506 -6.00 25,132 -18.60 0.0055
2020-08-14 2020-06-30 13F AXSOME THERAPEUTICS COM 05464T104 375,239 19,741 5.55 30,875 47.63 0.0073
2020-05-14 2020-03-31 13F AXSOME THERAPEUTICS COM 05464T104 355,498 22,931 6.90 20,914 -39.16 0.0060
2020-02-14 2019-12-31 13F AXSOME THERAPEUTICS COM 05464T104 332,567 -580 -0.17 34,374 409.77 0.0077
2019-11-13 2019-09-30 13F AXSOME THERAPEUTICS COM 05464T104 333,147 242,884 269.08 6,743 190.02 0.0016
2019-08-13 2019-06-30 13F AXSOME THERAPEUTICS COM 05464T104 90,263 54,905 155.28 2,325 362.23 0.0006
2019-05-13 2019-03-31 13F AXSOME THERAPEUTICS COM 05464T104 35,358 4,843 15.87 503 484.88 0.0001
2019-02-12 2018-12-31 13F AXSOME THERAPEUTICS COM 05464T104 30,515 0 0.00 86 -18.10 0.0000
2018-11-14 2018-09-30 13F AXSOME THERAPEUTICS COM 05464T104 30,515 0 0.00 105 8.25 0.0000
2018-09-18 2018-06-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 30,515 0 0.00 97 29.33 0.0000
2018-08-14 2018-06-30 13F AXSOME THERAPEUTICS COM 05464T104 30,515 0 97
2018-05-09 2018-03-31 13F AXSOME THERAPEUTICS COM 05464T104 30,515 -3,477 -10.23 75 -60.53 0.0000
2018-02-14 2017-12-31 13F AXSOME THERAPEUTICS COM 05464T104 33,992 -974 -2.79 190 -2.06 0.0000
2017-11-13 2017-09-30 13F AXSOME THERAPEUTICS COM 05464T104 34,966 0 0.00 194 1.04 0.0001
2017-08-11 2017-06-30 13F AXSOME THERAPEUTICS COM 05464T104 34,966 -77,233 -68.84 192 -56.06 0.0001
2017-05-12 2017-03-31 13F AXSOME THERAPEUTICS COM 05464T104 112,199 6,966 6.62 437 -38.54 0.0001
2017-02-13 2016-12-31 13F AXSOME THERAPEUTICS COM 05464T104 105,233 276 0.26 711 -14.03 0.0002
2016-11-09 2016-09-30 13F AXSOME THERAPEUTICS COM 05464T104 104,957 83,265 383.85 827 404.27 0.0003
2016-08-12 2016-06-30 13F AXSOME THERAPEUTICS COM 05464T104 21,692 21,692 164 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.